Our multi-disciplinary consortium brings together outstanding expertise consisting of 6 research institutions with leading scientists in their field, 2 SMEs and 1 NGO with expertise in ethical and social aspects of transplantation.
University of Geneva, Department of Surgery (UNIGE)
building. The mission of the CITC is to develop innovative therapies for the most severe forms of diabetes.
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Department of Health Sciences (UNIUPO)
Lyon Claude Bernard University, Transplantation Department, Edouard Herriot University Hospital (CHU-LYON)
IRCCS Ospedale San Raffaele, Diabetes Research Institute (OSR)
OSR integrates basic and clinical research through a translational approach, in which lab discoveries translate quickly into clinical therapies and clinical needs drive basic research. The institute aims at understanding the mechanisms underlying a variety of human diseases and at identifying new targets and therapeutic strategies to treat them.
Role within VANGUARD: OSR lead the functional assessment of bioartificial pancreas in vitro and in vivo experiments and support the assembly of the bioartificial pancreas.
Ludwig-Maximilians-Universität München, Diabetes Center (LMUM)
Kugelmeiers AG (KGM)
European Society for Organ Transplantation, Ethical, Legal and Psychosocial Aspects of organ Transplantation (ESOT-ELPAT)
accelopment AG (ACCEL)
Role within VANGUARD: ACCEL leads the work package on Stakeholder engagement, dissemination and exploitation and support UNIGE with the coordination and innovation management.
Role within VANGUARD: In VANGUARD, Erasmus MC is in the lead for the Ethical, Legal and Social Aspects (ELSA) of the project.